Synthesis of ribavirin 2’-Me-C-nucleoside analogues

Scholarly Works

• Wauchope, O. R. doi:10.1002/9780470682531.pat1018
• Micouin, L.; Piccardi, R. Organoaluminum Reagents. Comprehensive Organic Synthesis; Elsevier, 2025; pp 45–69. doi:10.1016/b978-0-323-96025-0.00041-7
• Singh, S.; Kaira, M.; Dey, H.; Pandey, K. C.; Tahlan, S.; Singh, K. Synthetic Methodology, SAR and Pharmacology of Commercialized Preparations Employing 1, 2, 4‐Triazole Analogues. ChemistrySelect 2024, 9. doi:10.1002/slct.202404350
• Nascimento, S. M. R. d.; Ferry, A.; Gallier, F.; Lubin-Germain, N.; Uziel, J.; Gonzales, S.; Miranda, L. S. d. M. E. Developments in the chemistry and biology of 1,2,3-triazolyl-C-nucleosides. Archiv der Pharmazie 2023, 357, e2300580. doi:10.1002/ardp.202300580
• Mukherjee, D.; Hudait, N.; Sakander, N.; Kundu, S.; Rasool, B.; Sengupta, J. Synthesis of Modified C-Nucleosides of Therapeutic Significant: A Succinct Account. Synlett 2023, 35, 635–648. doi:10.1055/a-2202-8808
• da Silva, E. F.; Antunes Fernandes, K. H.; Diedrich, D.; Gotardi, J.; Freire Franco, M. S.; Tomich de Paula da Silva, C. H.; Duarte de Souza, A. P.; Baggio Gnoatto, S. C. New triazole-substituted triterpene derivatives exhibiting anti-RSV activity: synthesis, biological evaluation, and molecular modeling. Beilstein journal of organic chemistry 2022, 18, 1524–1531. doi:10.3762/bjoc.18.161
• Bozinovic, N.; Aguiar, V. M. d.; Ferry, A.; Gallier, F.; Lubin-Germain, N.; Uziel, J.; Miranda, L. S. d. M. E. Studies on the synthesis of 1'-CN-triazolyl-C-ribosides. Organic & biomolecular chemistry 2022, 20, 7261–7269. doi:10.1039/d2ob01403c
• Potey, L.; Dudhe, A. C.; Tumme, D.; Dudhea, R.; Sable, P. The Concept of Repurposing in COVID-19 Infection. Coronaviruses 2022, 3. doi:10.2174/2666796703666220204102622
• Sharma, A.; Bera, S.; Mondal, D. Advances in the synthesis of antiviral agents from carbohydrate-derived chiral pools. Journal of Carbohydrate Chemistry 2022, 41, 424–510. doi:10.1080/07328303.2023.2189473
• Gonzalez, S.; Brzuska, G.; Ouarti, A.; Gallier, F.; Solarte, C.; Ferry, A.; Uziel, J.; Krol, E.; Lubin-Germain, N. Anti-HCV and Zika activities of ribavirin C-nucleosides analogues. Bioorganic & medicinal chemistry 2022, 68, 116858. doi:10.1016/j.bmc.2022.116858
• Takada, H.; Takizawa, N.; Shibasaki, S.; Asaba, H.; Igarashi, M.; Shibasaki, M.; Takahashi, Y. Synthesis and antiviral activity of formycin derivatives with anti-influenza virus activity. Bioorganic & medicinal chemistry 2022, 57, 116613. doi:10.1016/j.bmc.2022.116613
• Sabat, N.; Migianu-Griffoni, E.; Tudela, T.; Lecouvey, M.; Kellouche, S.; Carreiras, F.; Gallier, F.; Uziel, J.; Lubin-Germain, N. Synthesis and antitumor activities investigation of a C-nucleoside analogue of ribavirin. European journal of medicinal chemistry 2019, 188, 112009. doi:10.1016/j.ejmech.2019.112009
• Wambecke, A.; Laurent-Issartel, C.; Leroy-Dudal, J.; Giffard, F.; Cosson, F.; Lubin-Germain, N.; Uziel, J.; Kellouche, S.; Carreiras, F. Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells. PloS one 2019, 14, e0225860. doi:10.1371/journal.pone.0225860

Explore citations to this article at